Provided by Tiger Fintech (Singapore) Pte. Ltd.

AN2 Therapeutics, Inc.

1.24
+0.0000
Volume:44.53K
Turnover:54.63K
Market Cap:37.32M
PE:-0.72
High:1.24
Open:1.22
Low:1.21
Close:1.24
Loading ...
Mar 29, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 06, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2022

Major Issues Report

8-K - Current report
Apr 08, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 08, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals